ABSTRACT Introduction Soft mist inhalers (SMIs) are propellant-free inhalers that utilize
mechanical power to deliver single or multiple doses of inhalable drug aerosols in the form …

Abstract Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of
humanity for more than 2 years. In the meantime, the pandemic has caused economic …

Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …

Pulmonary infections are a leading cause of morbidity and mortality worldwide, a situation
exacerbated by the COVID-19. Azithromycin (AZM) is used orally to treat pulmonary …

In December 2019, the global coronavirus disease 2019 (COVID-19) pandemic began in
Wuhan, China. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 …

Unfractionated heparin has multiple pharmacological activities beyond anticoagulation.
These anti-inflammatory, anti-microbial, and mucoactive activities are shared in part by low …

Background The 2019 novel coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently a major challenge …

Systematic inflammatory response syndrome (SIRS) and the accompanying sepsis pose a
huge threat to human health worldwide. Heparin is a part of the standard supportive care for …

The vaccine weapon has resulted in being essential in fighting the COVID-19 outbreak, but it
is not fully preventing infection due to an alarming spreading of several identified variants of …

Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients
infected with influenza virus and most recently with SARS-CoV-2. However, poor …